| abstract |
The present invention relates to crystalline forms comprising telmisartan and at least one beta blocker, especially a selective receptor blocker {be} {sub, 1}, especially salts or co-crystals of telmisartan and a beta blocker, preferably selected from selective blockers of the receptor {be} {sub, 1}, procedures for preparing them and their use as a medicine or in pharmaceutical formulations, more particularly for the treatment of hypertension, heart failure and myocardial infarction. |